OXB — Oxford BioMedica Share News
0.000.00%
- £761.50m
- £813.05m
- £128.80m
REG - Oxford Biomedica PLC - PDMR Dealings
AnnouncementREG - Oxford Biomedica PLC - PDMR Dealing
AnnouncementREG - Oxford Biomedica PLC - Amendment of Short-Term Loan Facility
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Interim Results
AnnouncementREG - Oxford Biomedica PLC - Oxford Biomedica Solutions signs new partner
AnnouncementREG - Oxford Biomedica PLC - Licence & Supply Agreement with New Partner
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Notice of Interim Results
AnnouncementREG - Oxford Biomedica PLC - Oxford Biomedica Notes Homology Q2 Report
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Appointment of Joint Corporate Broker
AnnouncementREG - Oxford Biomedica PLC - New Project with Orchard Therapeutics
AnnouncementREG - Oxford Biomedica PLC - Licence & Supply Agreement with New Partner
AnnouncementREG - Oxford Biomedica PLC - Expanded Agreement with BMS’s Juno in CAR-T
AnnouncementREG - Oxford Biomedica PLC - BLOCK LISTING RETURN
AnnouncementREG - Oxford Biomedica PLC - Total Voting Rights
AnnouncementREG - Oxford Biomedica PLC - Signs new agreement with AstraZeneca
AnnouncementRCS - Oxford Biomedica PLC - Notes FDA lift clinical hold on pheNIX trial
Announcement